Literature DB >> 24064185

Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood.

Petroula Proitsi1, Sang Hyuck Lee, Katie Lunnon, Aoife Keohane, John Powell, Claire Troakes, Safa Al-Sarraj, Simon Furney, Hilkka Soininen, Iwona Kłoszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, Simon Lovestone, Angela Hodges.   

Abstract

An increased risk of developing Alzheimer's disease (AD) has previously been found to be associated with variants at the MS4A6A locus. We sought to identify which genes and transcripts in this region have altered expression in AD and mild cognitive impairment (MCI) and are influenced by the AD risk variant(s), as a first step to understanding the molecular basis of AD susceptibility at this locus. Common variants located within highly expressed MS4A6A transcripts were significantly associated with AD and MS4A6A expression levels in blood from MCI and AD subjects (p < 0.05, rs610932, rs7232, rs583791). More copies of the protective (minor) allele were associated with lower MS4A6A expression of each transcript (e.g., p = 0.019; rs610932-total MS4A6A). Furthermore, in heterozygous AD subjects, relative expression of the protective allele of V4-MS4A6A transcripts was lower (p < 0.008). Irrespective of genotype, MS4A6A transcripts were increased in blood from people with AD (p < 0.003), whereas lower expression of full length V1-MS4A6A (p = 0.002) and higher expression of V4-MS4A6A (p = 1.8 × 10(-4)) were observed in MCI, relative to elderly controls. The association between genotype and expression was less consistent in brain, although BA9 did have a similar genotype association with V4-MS4A6A transcripts as in blood. MS4A6A transcripts were widely expressed in tissues and cells, with the exception of V4-MS4A6A, which was not expressed in neuronal cells. Together these results suggest that high levels of MS4A6A in emerging AD pathology are detrimental. Persons with MCI may lower MS4A6A expression to minimize detrimental disease associated MS4A6A activity. However, those with the susceptibility allele appear unable to decrease expression sufficiently, which may explain their increased risk for developing AD. Inhibiting MS4A6A may therefore promote a more neuroprotective phenotype, although further work is needed to establish whether this is the case.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; MCI; MS4A genes; MS4A6A; eQTL; gene expression; genetic susceptibility

Mesh:

Substances:

Year:  2013        PMID: 24064185     DOI: 10.1016/j.neurobiolaging.2013.08.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  19 in total

Review 1.  The MS4A family: counting past 1, 2 and 3.

Authors:  Li Eon Kuek; Melanie Leffler; Graham A Mackay; Mark D Hulett
Journal:  Immunol Cell Biol       Date:  2015-04-03       Impact factor: 5.126

2.  A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure.

Authors:  Hannu Turpeinen; Ilkka Seppälä; Leo-Pekka Lyytikäinen; Emma Raitoharju; Nina Hutri-Kähönen; Mari Levula; Niku Oksala; Melanie Waldenberger; Norman Klopp; Thomas Illig; Nina Mononen; Reijo Laaksonen; Olli Raitakari; Mika Kähönen; Terho Lehtimäki; Marko Pesu
Journal:  Hum Genet       Date:  2015-03-27       Impact factor: 4.132

Review 3.  MS4A Cluster in Alzheimer's Disease.

Authors:  Jing Ma; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-07-01       Impact factor: 5.590

Review 4.  Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.

Authors:  Amanda McQuade; Mathew Blurton-Jones
Journal:  J Mol Biol       Date:  2019-02-07       Impact factor: 5.469

5.  Aging Shapes the Population-Mean and -Dispersion of Gene Expression in Human Brains.

Authors:  Candice L Brinkmeyer-Langford; Jinting Guan; Guoli Ji; James J Cai
Journal:  Front Aging Neurosci       Date:  2016-08-03       Impact factor: 5.750

6.  Hippocampal subregions exhibit both distinct and shared transcriptomic responses to aging and nonneurodegenerative cognitive decline.

Authors:  Dustin R Masser; Georgina V Bixler; Robert M Brucklacher; Han Yan; Cory B Giles; Jonathan D Wren; William E Sonntag; Willard M Freeman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-07-02       Impact factor: 6.053

7.  GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease.

Authors:  Jie-Qiong Li; Hui-Fu Wang; Xi-Chen Zhu; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

8.  Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.

Authors:  Weidong Ji; Lanling Xu; Haiyun Zhou; Suishan Wang; Yan Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease.

Authors:  Samuel Morabito; Emily Miyoshi; Neethu Michael; Vivek Swarup
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

Review 10.  Microglial malfunction: the third rail in the development of Alzheimer's disease.

Authors:  Siddhita D Mhatre; Connie A Tsai; Amanda J Rubin; Michelle L James; Katrin I Andreasson
Journal:  Trends Neurosci       Date:  2015-10       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.